0001127602-23-024071.txt : 20230913 0001127602-23-024071.hdr.sgml : 20230913 20230913162038 ACCESSION NUMBER: 0001127602-23-024071 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230911 FILED AS OF DATE: 20230913 DATE AS OF CHANGE: 20230913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lingamneni Anila CENTRAL INDEX KEY: 0001808414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 231252936 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0330 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-09-11 0000313143 HAEMONETICS CORP HAE 0001808414 Lingamneni Anila 125 SUMMER STREET BOSTON MA 02110 1 EVP, Chief Technology Officer 1 Common Stock 2023-09-11 4 S 0 2305 90.00 D 14495 D Transaction pursuant to an existing 10b5-1 trading plan dated June 2, 2023 (fully executed as of June 5, 2023). This number includes unvested restricted stock units previously reported. /s/ Thomas V. Powers, attorney-in-fact for Ms. Lingamneni 2023-09-13